Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$17.38 - $21.54 $2.74 Million - $3.4 Million
-157,759 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$18.47 - $22.11 $5.17 Million - $6.19 Million
-279,780 Reduced 63.94%
157,759 $3 Million
Q1 2021

May 11, 2021

BUY
$19.22 - $24.3 $2.56 Million - $3.23 Million
132,976 Added 43.66%
437,539 $8.41 Million
Q4 2020

Feb 05, 2021

BUY
$18.2 - $22.45 $5.54 Million - $6.84 Million
304,563 New
304,563 $6.56 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.